Literature DB >> 26187009

Stopping MYC in its tracks.

Eduard Stefan1, Jonathan R Hart2, Klaus Bister1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26187009      PMCID： PMC4543033          DOI： 10.18632/aging.100780

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN： 1945-4589            Impact factor:   5.682


× No keyword cloud information.
  7 in total

Review 1.  An overview of MYC and its interactome.

Authors:  Maralice Conacci-Sorrell; Lisa McFerrin; Robert N Eisenman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 2.  Retroviral oncogenes: a historical primer.

Authors:  Peter K Vogt
Journal:  Nat Rev Cancer       Date:  2012-08-17       Impact factor: 60.716

Review 3.  MYC on the path to cancer.

Authors:  Chi V Dang
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

4.  Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts.

Authors:  Thorsten Berg; Steven B Cohen; Joel Desharnais; Corinna Sonderegger; Daniel J Maslyar; Joel Goldberg; Dale L Boger; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

5.  Modelling Myc inhibition as a cancer therapy.

Authors:  Laura Soucek; Jonathan Whitfield; Carla P Martins; Andrew J Finch; Daniel J Murphy; Nicole M Sodir; Anthony N Karnezis; Lamorna Brown Swigart; Sergio Nasi; Gerard I Evan
Journal:  Nature       Date:  2008-08-17       Impact factor: 49.962

6.  Inhibitor of MYC identified in a Kröhnke pyridine library.

Authors:  Jonathan R Hart; Amanda L Garner; Jing Yu; Yoshihiro Ito; Minghao Sun; Lynn Ueno; Jin-Kyu Rhee; Michael M Baksh; Eduard Stefan; Markus Hartl; Klaus Bister; Peter K Vogt; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

7.  In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential.

Authors:  Philipp Raffeiner; Ruth Röck; Andrea Schraffl; Markus Hartl; Jonathan R Hart; Kim D Janda; Peter K Vogt; Eduard Stefan; Klaus Bister
Journal:  Oncotarget       Date:  2014-10-15
  7 in total
  2 in total

Review 1.  MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human Cancer.

Authors:  Eduard Stefan; Klaus Bister
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

2.  Calcium-dependent binding of Myc to calmodulin.

Authors:  Philipp Raffeiner; Andrea Schraffl; Thomas Schwarz; Ruth Röck; Karin Ledolter; Markus Hartl; Robert Konrat; Eduard Stefan; Klaus Bister
Journal:  Oncotarget       Date:  2017-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.